Patients undergoing radical prostatectomy in generel anesthesia MedDRA version: 14.1 Level: LLT Classification code 10007113 Term: Cancer of prostate System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Age > 18 years - Males - Indication for radical prostatectomy Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: - Blooddonation within the last month - Lack of wish to participate - eGFR< 15ml/min
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: The objective is for elective laparoscopic nephrectomy to measure the effect of hydroxyethyl starch on biomarkers of nephrotoxicity (U-Alb, u- NGAL, u-Kim 1, u-FABP) ;Secondary Objective: Secondarily to measure the effect of hydroxyethyl starch on the renal tubular transport of sodium and water (FENa, u-ENaCß, CH2O, u-AQP2, u-NCC, u-NK2CC), vasoactive hormones (PRC, p-Ang-II, p -Aldo, p-ANP, P-GDP, p-AVP, p-Endot), central hemodynamics (SBP, DBP, heart rate) and on the glycocalyx layer of the endothelium (syndecan-1) during elective radical prostatectomy;Primary end point(s): u- NGAL | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): PRC, p-Ang-II, p-Aldo, p-ANP, p-BNP, p-AVP, p-Endot, CH2O, u-AQP2, FENa u- EnaCß, u-Alb, u-Kim 1, u-FABP, u-NCC, u-NK2CC, heart rate, SBP, DBP and Syndecan-1 | — |
Countries
Denmark
Contacts
Regionshospitalet Holstebro